Latest Breaking News On - Banner neurodegenerative disease research center - Page 1 : comparemela.com

Study reveals pivotal insights into the progression of Parkinson's disease

Parkinson's disease, the second most common type of progressive dementia after Alzheimer's disease, affects nearly 1 million people in the U.S. and an estimated 10 million individuals worldwide.

New research challenges conventional picture

<p>In a new study,&nbsp;<a href="https://search.asu.edu/profile/3942692">Jeffrey Kordower</a>, director of the&nbsp;<a href="https://biodesign.asu.edu/neurodegenerative-disease/">ASU-Banner Neurodegenerative Disease Research Center</a>, and his colleagues unveil pivotal insights into the progression of Parkinson&#39;s disease, presenting new hope for patients battling the severely debilitating disorder.</p> <p>The research highlights the role of a critical protein called tau in the early stages of the disease. The results suggest that aggregates of the tau protein may jump-start processes of neuronal damage and death characteristics of the disease.</p>

Research Upends Traditional View of Parkinson's Disease

New research challenges conventional picture of Parkinson's disease

Researchers develop drug to treat Alzheimer's disease in Down syndrome patients

Research on the drug, known as DYR533, was conducted at the the University of Arizona R. Ken Coit College of Pharmacy and BIO5 Institute, in partnership with the Biodesign Institute in Phoenix.